Company intelligence / Profile preview

Future Kind

USA

Ownership: Private
Development stage: Other

Overview

Future Kind develops and sells vegan nutritional supplements formulated to address key nutrient needs such as vitamin B12, vitamin D3, and Omega-3 for those on plant-based diets. The company is active, with a focus on transparent manufacturing (GMP/FDA regulated, USA-based), third-party testing, sustainability, and animal sanctuary support. There are no clinical trial results as this is not a drug developer.

Therapeutic areas: Metabolic DisordersOther
Modalities: Dietary supplements
Industry: Food & Nutrition

Partnerships

Vegan animal sanctuaries and charities

Beyond the preview

Go deeper on Future Kind.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Future Kind.

Explore the full profile